Novo Nordisk completes Forma Therapeutics acquisition
![Photo: Novo Nordisk / PR](https://photos.watchmedier.dk/watchmedier/resize:fill:3840:0:0/plain/https://photos.watchmedier.dk/Images/article14496856.ece/ALTERNATES/schema-16_9/doc7n69necpwbp9h23lq6.jpg)
Novo Nordisk has announced that the acquisition of Forma Therapeutics, which specializes in sickle cell disease and rare blood disorders, has been completed, a company press release reports.
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
Get full access for you and your coworkers
Start a free company trial todayRelated articles
Novo Nordisk to acquire Forma Therapeutics in USD 1.1bn deal
For subscribers